Results
|
|
1741.
|
|
|
|
1742.
|
|
|
|
1743.
|
|
|
|
1744.
|
|
|
|
1745.
|
|
|
|
1746.
|
|
|
|
1747.
|
|
|
|
1748.
|
|
|
|
1749.
|
|
|
|
1750.
|
|
|
|
1751.
|
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus. [electronic resource] by
- Stefani, A
- Fedele, E
- Vitek, J
- Pierantozzi, M
- Galati, S
- Marzetti, F
- Peppe, A
- Bassi, M S
- Bernardi, G
- Stanzione, P
Producer: 20111101
In:
Cell death & disease vol. 2
Availability: No items available.
|
|
|
1752.
|
|
|
|
1753.
|
|
|
|
1754.
|
|
|
|
1755.
|
|
|
|
1756.
|
|
|
|
1757.
|
|
|
|
1758.
|
|
|
|
1759.
|
Advanced target identification in STN-DBS with beta power of combined local field potentials and spiking activity. [electronic resource] by
- Verhagen, Rens
- Zwartjes, Daphne G M
- Heida, Tjitske
- Wiegers, Evita C
- Contarino, M Fiorella
- de Bie, Rob M A
- van den Munckhof, Pepijn
- Schuurman, P Richard
- Veltink, Peter H
- Bour, Lo J
Producer: 20160601
In:
Journal of neuroscience methods vol. 253
Availability: No items available.
|
|
|
1760.
|
|